Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Armstrong, Matthew James, PhD, Gaunt, Piers, MSc, Aithal, Guruprasad P, PhD, Barton, Darren, BSc, Hull, Diana, MSc, Parker, Richard, MBChB, Hazlehurst, Jonathan M, MBChB, Guo, Kathy, MSc, Abouda, George, MBChB, Aldersley, Mark A, PhD, Stocken, Deborah, PhD, Gough, Stephen C, Prof, Tomlinson, Jeremy W, Prof, Brown, Rachel M, MBChB, Hübscher, Stefan G, Prof, Newsome, Philip N, Prof
Published in The Lancet (British edition) (13.02.2016)
Published in The Lancet (British edition) (13.02.2016)
Get full text
Journal Article
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes
Gough, Stephen C L, Prof, Bode, Bruce, MD, Woo, Vincent, MD, Rodbard, Helena W, MD, Linjawi, Sultan, MD, Poulsen, Pernille, MD, Damgaard, Lars H, PhD, Buse, John B, Prof
Published in The lancet. Diabetes & endocrinology (01.11.2014)
Published in The lancet. Diabetes & endocrinology (01.11.2014)
Get full text
Journal Article